Substance / Medication

Arformoterol

Overview

Active Ingredient
arformoterol
RxNorm CUI
304962

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

18 trials linked to this intervention

18
Total Trials
2
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma.
Hinkle J, Hinson J, Kerwin E et al. · Pediatr Pulmonol · 2011
PMID: 21584948RCT
Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.
Donohue James F, Bollu Vamsi K, Stull Donald E et al. · Int J Chron Obstruct Pulmon Dis · 2018
PMID: 29440887TrialFull text (PMC)
Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials.
Hanrahan John P, Hanania Nicola A, Calhoun William J et al. · COPD · 2008
PMID: 18259972Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Arformoterol (substance)
SNOMED CT
423347007
UMLS CUI
C0969589
RxNorm CUI
304962

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
18
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.